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  One－hundred－and－twenty patients with histoiogically proved prostatic carcinoma were treated
at the Center for Adult Diseases， Osaka between 1960 and 1979． Of 120 patients， 29 were classified
into poorly differentiated adenocarcinoma． Of 29 patients， 27 had either estrogen therapy or an
orchiectomy， or both， 2 had total prostatectomy， 5 received radiation therapy and 5 had chemotherapy．
  Five year relative survival rate of patients with poorly differentiated carcinoma of the prostate
was 11．90／o． Nonhormonal chemotherapy and radiation therapy were usefu1 for patients with advanced
poorly differentiated adenocarcinoma of the prostate．
るとともに，今後の治療方針について考察する．
は じ め に























 臨床進展度はWhitmoreの分類1こ従えば， stage A
1例（3％），stage B 8例（28％）， stage C 12例




Table 3． Effect of anti－androgenic








無 効 3例 （11％）
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Fig． 1． Age distribution of patients with
    pooriy differentiated adenocarcinoma
    of the prostate
Table 1． Clinical stage of patients with poorly
     differentiated adenocarcinoma of the
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剤  投与法  投  与  量   投与期間 効果
1319
症例  薬















IV   l 200mg／日     12日
   ｛           著効
   i 10σmg／日     35日
PO   600mg／日    8週  無効
IV 20mg／日十250mg／日 1日十5日 無効
 1）ペプレオマイシン IV
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6  エンドキサン IV 200mg／日 3日  無効
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Fig． 2． Schema of clinical course of a case with pooriy
    differentiated adenocarcinoma of the prostate
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Fig． 3． Survival in patients with cancer of the prostate and poorly



































































たてている．     ．       、
  1）stage Bで70歳未満の場合，根治的前立腺摘除
術を施行する．
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